DexCom Inc (DXCM)
DXCM Announcement: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
Merck & Company Inc (MRK)
Merck Recommends Rejection ofTutanota’s “Mini-Tender” Offer
United Therapeutics Corporation (UTHR)
UTHR: Notification
Exact Sciences Corporation (EXAS)
4 (Statement of Changes in Beneficial Ownership) SEC Filing
Iovance Biotherapeutics Inc (IOVA)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
TEVA (TEVA)
Teva Pharmaceutical Industries Ltd. - Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December
Ultragenyx Pharmaceutical Inc (RARE)
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Olema Oncology (OLMA)
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
Teva Pharmaceutical Industries Limited (TEVA)
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December
cbdMD Inc. (YCBD)
Notification from cbdMD, Inc.